-- Meesho(NSE:MEESHO,BOM:544632)公布,截至3月31日的第四财季,其合并应占亏损收窄至16.6亿印度卢比,而去年同期亏损为139亿卢比。 这家在线市场平台周三向印度证券交易所提交的文件显示,每股亏损收窄至0.36卢比,而去年同期每股亏损为3.39卢比。这一每股亏损低于Visible Alpha调查的分析师此前预测的0.73卢比。 第四财季的营业收入从去年同期的240亿卢比增至353亿卢比,略高于Visible Alpha此前预测的352亿卢比。
Related Articles
Humanwell Healthcare Gets Clinical Trial Approval for Opioid Alternative
Humanwell Healthcare (SHA:600079) unit obtained China's regulatory approval to begin clinical trials for RFUS-188 to treat acute pain, according to a Thursday filing with the Shanghai bourse.The drug targets peripheral kappa opioid receptors without crossing the blood-brain barrier, potentially eliminating the addiction, respiratory depression and other severe side effects of traditional opioidsShares of the pharmaceutical company declined 1% in recent trade.
Tibet Huayu Mining Shareholder to Divest 1% Stake in Company
A Tibet Huayu Mining (SHA:601020) shareholder plans to reduce part of its holdings to meet its own business development needs, according to a Shanghai bourse filing on Thursday.Qinghai Western Rare Precious Metals will offload 8,200,000 shares, or around 1% of the mining company's total shares, between May 29 and Aug. 28.Qinghai Western Rare Precious Metals currently owns 72,336,364 shares, or 8.8% of the company's total shares.
Taiwan Mask Mulls Private Placement of Up to 20 Million Shares; Shares Rally 10%
Taiwan Mask (TPE:2338) board approved a plan to privately place up to 20 million shares in one to three tranches within a year, according to a filing with the Taiwan Exchange on Wednesday.Shares of the photomask manufacturer jumped about 10% in Thursday's midday trade.Proceeds from the offering are earmarked for working capital, factory expansion, machinery and equipment procurement, debt repayment, and other long-term development needs.Potential subscribers may include insider and related parties such as Luminous Rise Investment, TrueLight Corp., Star Fusion Group, and ALi Corp. (TPE:3041), although no final placees have been selected, it said.